Ribavirin is primarily used in the treatment of chronic hepatitis C, often in combination with other antiviral medications like interferon or direct-acting antivirals. It works by inhibiting viral RNA synthesis, thereby reducing the viral load in the body. This helps in managing the infection and preventing liver damage. Additionally, Ribavirin is utilized in treating respiratory syncytial virus (RSV) infections, particularly in hospitalized infants and young children who are at high risk of severe complications. It is administered via aerosol to directly target the respiratory tract. In some cases, Ribavirin is also employed for treating viral hemorrhagic fevers, such as Lassa fever, when other treatment options are limited. Its broad-spectrum antiviral activity makes it a valuable option in managing these severe and often life-threatening conditions. However, its use is carefully monitored due to potential side effects, including anemia and teratogenicity, requiring strict adherence to safety guidelines during treatment.